Logo

Genetic Technologies

Genetic Technologies Gets Nasdaq Delisting Warning

The Australian genomic testing company said that its American Depositary Shares have failed to meet the Nasdaq's minimum bid price requirement for continued listing.

In Brief This Week: OpGen, MDxHealth, Dante Genomics, More

New items for the week of Oct. 24, 2022.

In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More

News items for the week of July 11, 2022.

Genetic Technologies Lab Gets Regulatory Approvals in US, Australia

The lab has received NATA accreditation and CLIA certification, enabling the launch of the company's multi-disease risk assessment test in Australia and the US.

In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More

News items for the week of Jan. 17, 2022. 

Sep 28, 2021

Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent

Aug 31, 2021

Genetic Technologies Fiscal Year 2021 Revenues Soar on COVID-19 Test Alliance

Jul 19, 2021

Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA for $4M

Mar 4, 2021

Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix

Jan 21, 2021

Genetic Technologies to Raise $6.6M in Direct Offering

Dec 2, 2020

Genetic Technologies Lands Distribution Rights to Taliaz Antidepressant Drug Selection Tools

Sep 2, 2020

Genetic Technologies Regains Compliance With Rules for Nasdaq Listing

Jul 16, 2020

Genetic Technologies to Raise $5.1M in Direct Offering

May 26, 2020

Genetic Technologies Prices $8M Public Offering

Apr 20, 2020

Genetic Technologies Prices $1.4M Direct Offering

Apr 1, 2020

Genetic Technologies Inks Deals to Raise A$1.8M

Mar 16, 2020

Genetic Technologies Receives Nasdaq Delisting Notification

May 22, 2019

Genetic Technologies Offers $1.2M in American Depositary Shares

May 3, 2019

Genetic Technologies Out of Compliance With Nasdaq Listing Rules

Apr 15, 2019

Genetic Technologies, TGen to Launch Genetic Tests in US

Feb 1, 2019

Genetic Technologies, Cancer Centers to Study Breast Cancer Polygenic Risk Score Impact

Dec 21, 2018

In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More

Aug 16, 2018

Genetic Technologies Announces Planned Chinese Joint Venture

Aug 8, 2018

Genetic Technologies Inks A$20M Equity Placement Deal

Jul 30, 2018

Genetic Technologies, Swisstec Ink Asian Distribution Deal

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.